About Us

Advancing Precision Genetic Therapies With the Potential to Restore, Improve and Preserve Hearing

Listening is in our DNA.

Ακούω in Greek translates to Listen in English. At Akouos (ah KOO ohs), we strive to be a team that listens to one another, to healthcare providers, and to the deaf and hard of hearing (D/HH) community. Our partnerships and collaborations are focused on common goals and predicated on respect, trust, and transparency.

Common Goal Partnerships

In partnering with the D/HH community, we will use the principles outlined here as our guide.

Hearing loss is one of the greatest challenges in medicine today, and with no FDA-approved pharmacologic therapies available, an area of severe unmet need.

Manny Simons, PH.Dfounder and CEO of Akouos

We Are Akouos

  • Filter By:

  • Ryan Anderson

    ANATOMY & PHYSIOLOGY

  • Eva Andres-Mateos

    TRANSLATIONAL MEDICINE

  • Yukako Asai

    ANATOMY & PHYSIOLOGY

  • Priya Bansode

    AAV MOLECULAR BIOLOGY

  • Jean Bennett

    SCIENTIFIC ADVISORY BOARD

  • Liz Bougoulas

    FINANCE

  • Frima Bourtman

    PROGRAM MANAGEMENT

  • Timothy Boyd

    PROCESS & ANALYTICAL DEVELOPMENT

  • Bethany Calagione

    LEGAL

  • Robyn Chiang

    AAV MOLECULAR BIOLOGY

  • Rick Churchill

    AAV MOLECULAR BIOLOGY

  • John Connelly

    SENIOR VICE PRESIDENT, PORTFOLIO STRATEGY & R&D OPERATIONS

  • Yuanzhao Darcy

    ANATOMY & PHYSIOLOGY

  • Samantha Davis

    ANATOMY & PHYSIOLOGY

  • Shimon Francis

    ANATOMY & PHYSIOLOGY

  • Yuan Gao

    ANATOMY & PHYSIOLOGY

  • Alan Gilstrap

    ADVOCACY & ENGAGEMENT

  • Katherine Gribble

    AAV MOLECULAR BIOLOGY

  • Lakeija Hall

    OFFICE MANAGEMENT

  • Tyler Halloran

    CLINICAL DEVELOPMENT

  • Brittany Hasili

    FINANCE

  • Christian Heath

    OPERATIONS

  • Joey Henry

    ANATOMY & PHYSIOLOGY

  • Ann Hickox

    REGULATORY AFFAIRS

  • Eric Horowitz

    PROCESS & ANALYTICAL DEVELOPMENT

  • Ivy Hughes

    PROCESS & ANALYTICAL DEVELOPMENT

  • Sara Kangas

    FINANCE

  • Aninda Katragadda

    FINANCE CONSULTANT

  • Judith Kelley

    EXECUTIVE ADMINISTRATION

  • Ventsi Kichikov

    IT

  • Ye-Hyun Kim

    ANATOMY & PHYSIOLOGY

  • Mary LeBlanc

    FINANCE

  • Kathy Lennon

    CLINICAL

  • Danielle Lenz

    AAV MOLECULAR BIOLOGY

  • Rodrigo Lopez

    PROCESS & ANALYTICAL DEVELOPMENT

  • Alex Martinez

    ANATOMY & PHYSIOLOGY

  • Ed Mathers

    BOARD OF DIRECTORS

  • Sam Maxwell

    PROCESS & ANALYTICAL DEVELOPMENT

  • Patrick McCarthy

    PROCESS & ANALYTICAL DEVELOPMENT

  • Michael McKenna

    CHIEF MEDICAL OFFICER & CO-FOUNDER

  • Jim McLaughlin

    MEDICAL WRITING

  • Jennifer Meaney

    HUMAN RESOURCES

  • Sachiyo Minegishi

    CHIEF FINANCIAL OFFICER

  • Morgan Molloy

    CHIEF CORPORATE DEVELOPMENT OFFICER

  • Joe Mombeleur

    PROCESS & ANALYTICAL DEVELOPMENT

  • Robert Ng

    AAV MOLECULAR BIOLOGY

  • Rabia Gurses Ozden

    CHIEF DEVELOPMENT OFFICER

  • Damla Ozen

    IT

  • Bifeng Pan

    ANATOMY & PHYSIOLOGY

  • Dan Paquette

    OPERATIONS

  • Kush Parmar

    BOARD OF DIRECTORS

  • Amy Perniciaro

    CLINICAL DEVELOPMENT

  • Jean Phillips

    CLINICAL

  • Heather Preston

    BOARD OF DIRECTORS

  • Frank Puig-Basagoiti

    TRANSLATIONAL MEDICINE

  • Enping Qu

    AAV MOLECULAR BIOLOGY

  • Saira Ramasastry

    BOARD OF DIRECTORS

  • Greg Robinson

    CHIEF SCIENTIFIC OFFICER

  • Jennifer Santos

    ANATOMY & PHYSIOLOGY

  • Vicki Sato

    BOARD OF DIRECTORS

  • Pascal Schamber

    ANATOMY & PHYSIOLOGY

  • William Sewell

    FOUNDER

  • Karoline Shair

    CHIEF LEGAL OFFICER & CORPORATE SECRETARY

  • Emmanuel Simons

    PRESIDENT & CO-FOUNDER

  • Alan Smith

    CHIEF TECHNOLOGY OFFICER

  • Chris Smith

    BOARD OF DIRECTORS

  • Richard Smith

    FOUNDER

  • Jenna Soper

    PROGRAM MANAGEMENT

  • Junaid Syed

    ANATOMY & PHYSIOLOGY

  • Aaron Tward

    SCIENTIFIC ADVISORY BOARD

  • Arthur Tzianabos

    BOARD OF DIRECTORS

  • Michelle Valero

    ANATOMY & PHYSIOLOGY

  • Luk Vandenberghe

    FOUNDER

  • Katie Wachtel

    REGULATORY AFFAIRS

  • Suzanne Walker

    EXECUTIVE ADMINISTRATION

  • Jennifer Wellman

    CHIEF OPERATING OFFICER

  • Brianna Whelan

    OPERATIONS

  • Ru Xiao

    PROCESS & ANALYTICAL DEVELOPMENT

  • Jonathan Yeh

    PROCESS & ANALYTICAL DEVELOPMENT

Our Partners

Join us in the pursuit of healthy hearing for all.

What’s at our core

We Work to Change Lives

Akouos listens: to each other, to the individuals and families we work to serve, to our collective conscience.
Akouos engages: Honestly, transparently, respectfully.
Akouos leads: Authentically, boldly, bravely, with purpose and passion.
Akouos creates: High standards, opportunities to excel, better medicines.
Akouos trusts: Ourselves, each other, our science.

Join us in the pursuit of healthy hearing for all.

Akouos is building a leading gene therapy company focused on hearing disorders. Our objectives are to restore the inner ear’s ability to produce functional proteins required for hearing, rejuvenate structures of the hearing circuit critical for high-fidelity signal transduction and inner ear homeostasis, and reinforce healthy hearing with local, enduring protein production to protect against drug-, noise-, and age- associated ototoxicity.